Navigation Links
Delcath Expands Board of Directors With Appointment of Gabriel Leung
Date:3/31/2011

NEW YORK, March 31, 2011 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a development stage, specialty pharmaceutical and medical device company focused on oncology, announced today the appointment of Gabriel Leung, M.Sc. to the Company's expanded Board of Directors, effective immediately. The Company increased the size of its Board of Directors from seven to eight and appointed Mr. Leung to fill this new vacancy.  Mr. Leung will serve as a Class III director with a term expiring at the 2012 annual stockholder meeting.

With more than 20 years in the oncology pharmaceuticals marketplace and broad scientific expertise, Mr. Leung brings a wealth of experience in successfully gaining regulatory approval for and launching oncology drugs.  Mr. Leung most recently served as President of the Pharmaceuticals Business at OSI Pharmaceuticals, overseeing its oncology, diabetes and obesity businesses prior to the Company's acquisition by Astellas Pharma Inc. in June 2010. During his seven years at OSI, Mr. Leung held several senior management positions, led the successful filing of two supplemental New Drug Applications (NDA) for Tarceva® (erlotinib) and guided it to the most successful launch in U.S. oncology history with global sales exceeding $1.2 billion in 2009.  During this time, OSI's market capitalization increased from $1.4 billion to approximately $4.0 billion at the time of acquisition.

Prior to OSI, Mr. Leung served as Group Vice President, Global Prescription Business & Head of the Global Oncology Franchise for Pharmacia Corporation.  At Pharmacia, Mr. Leung served on the CEO's Corporate Operating Committee, overseeing all oncology clinical development projects and the discovery portfolio strategy that led to four successful ODAC panel recommendations and NDA/sNDA approvals. Previously, Mr. Leung held several leadership positions at
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath to Present at Upcoming Investor Conferences
2. Delcath Systems Receives Refusal to File Letter From FDA
3. Delcath Achieves ISO 13485 Certification
4. Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
5. Delcath Systems Announces Third Quarter Progress Report Conference Call
6. Delcath Strengthens Research and Development Team with Key Appointments
7. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
8. Delcath to Present at the William Blair Emerging Growth Stock Conference
9. Delcath to Present at the JMP Securities Healthcare Conference
10. Delcath Systems Announces Completion of Common Stock Offering
11. Delcath to Present at the 30th Annual Canaccord Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Research and Markets has announced ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study ... devices. The report provides a basic ... and industry chain structure. The laparoscopic devices market ...
(Date:9/16/2014)... 2014 On September 25 to 26, 2014, ... medical design and manufacturing - MEDTEC China  - will ... Exhibition & Convention Center, bringing together close to 300 ... showcase their latest medical-grade raw materials, parts and processing ... remaining for free visitor pre-registration to be completed. To ...
(Date:9/16/2014)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW ... for solid tumor cancers, announced today that its DCVax-L ... a "Promising Innovative Medicine" (PIM) under the new "Early ... in April 2014.  A PIM is the first step ... the EAMS.  The PIM designation for ...
Breaking Medicine Technology:Global Laparoscopy Devices Industry Report 2014 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5
... YORK, Sept. 22, 2011 Reportlinker.com ... report is available in its catalogue: ... Contract Pharmaceutical Manufacturing, Research And Packaging: ... http://www.reportlinker.com/p0619263/Global-Markets-for-Contract-Pharmaceutical-Manufacturing-Research-And-Packaging-Focus-on-Emerging-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing ...
... announces that a new market research report is ... Drugs: The Global Market--Focus on Asia ... REPORT CONTAINS * An examination ... generics to meet the challenges of this highly ...
Cached Medicine Technology:Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 2Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 3Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 4Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 5Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 6Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 7Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 8Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 9Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 10Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 11Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 12Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 13Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 14Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 15Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 16Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 17Generic Drugs: The Global Market--Focus on Asia 2Generic Drugs: The Global Market--Focus on Asia 3Generic Drugs: The Global Market--Focus on Asia 4Generic Drugs: The Global Market--Focus on Asia 5Generic Drugs: The Global Market--Focus on Asia 6Generic Drugs: The Global Market--Focus on Asia 7Generic Drugs: The Global Market--Focus on Asia 8Generic Drugs: The Global Market--Focus on Asia 9
(Date:9/16/2014)... Kathleen Doheny HealthDay Reporter ... simple urine test can routinely spot human papillomavirus (HPV), which ... analysis found. "Our study shows that testing urine for ... from the cervix for HPV," said lead researcher Dr. Neha ... research fellow at Queen Mary University of London, England. ...
(Date:9/16/2014)... Orlando, Florida (PRWEB) September 16, 2014 These ... the last 3 years to receive up to $10,000 in ... This program, as well as other state and federal programs, ... have to be paid back until you sell or move ... loan is a 0% interest loan. There are no monthly ...
(Date:9/16/2014)... 14, 2014 A new study found that ... stenting of true coronary bifurcation lesions yields similar ... DKCRUSH-VI clinical trial is the first study to ... were reported today at the 26th annual Transcatheter ... Cardiovascular Research Foundation (CRF), TCT is the world,s ...
(Date:9/16/2014)... Programs and policies that promote health ... of dollars in savings for the US health system, ... To help spur these types of improvements, the National ... groups from across the country to field test the ... a handbook designed to assist groups working together to ...
(Date:9/16/2014)... 16, 2014 As part of its ... American Citizens (LULAC) will host the second annual health ... will feature free health screenings for osteoporosis, HIV, and ... glucose and cholesterol levels as well as bone marrow ... children under 6 years old , The event will ...
Breaking Medicine News(10 mins):Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 3Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2
... , , WARRENVILLE, Ill., Aug. 5 ... ) is reaching out to key members of Congress to offer ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090804/UCAOALOGO ) ... care is a critical part of any patient-centered health care system, ...
... , , , ... Barrett has been elected to the company,s board of directors and will ... the completion of the planned spinoff of CareFusion Corp. on Aug. 31. ... chief executive officer of the company,s Healthcare Supply Chain Services segment since ...
... , Sen. Sherrod Brown, Public Health Insurance ... Reform Stand, Need To Hold Insurers Accountable , , ... will join health care expert Jacob Hacker and Campaign for ... call Thursday morning to brief reporters on a new analysis that shows ...
... , , BOSTON, Aug. ... a proposed $41.5 million settlement with drug manufacturers Merck & ... SGP ) to settle allegations the companies suppressed ... Vytorin and Zetia. Merck and Schering-Plough previously settled similar ...
... MaxLife Fund Corp. (OTC:MXFD), have announced that some of ... of 14,050,000 shares of the Company,s common stock in ... , Bennett Kurtz, Chief Executive Officer of the Company ... for our Company to increase shareholder value and support ...
... ... of prime labels with new site enhancements. The site enhancements provide customers with a ... , ... (PRWEB) August 5, 2009 -- My1Stop.com, the commercial printing superstore, launched upgraded prime label ...
Cached Medicine News:Health News:Urgent Care Association of America Launches Program to Educate Congress on Urgent Care 2Health News:George Barrett Named Chairman and CEO of Cardinal Health 2Health News:George Barrett Named Chairman and CEO of Cardinal Health 3Health News:George Barrett Named Chairman and CEO of Cardinal Health 4Health News:Sen. Brown, Hacker, to Release New Paper On How Public Plan in House and Senate Bills Measure Up 2Health News:Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million 2Health News:Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million 3Health News:MaxLife Fund Corp. announces cancellation of 14,050,000 Common Shares 2Health News:My1Stop.com Completes Upgrades to Prime Labels Offering and Easy Ordering Page Design 2
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Micro emulsifying needles, 18G....
Micro 2000, micro scissors micro 2000 supercut....
Yasargil clip applying forceps Mini. Stainless steel jaw....
Medicine Products: